NVMI holder plans Rule 144 sale of 9,346 shares

Nova Measuring Instruments ordinary shares are being prepared for sale under Rule 144.

Accepted by SEC EDGAR 02/17/2026 - 08:01 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Nova Measuring Instruments ordinary shares are being prepared for sale under Rule 144. A holder has filed to potentially sell 9,346 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $4,147,380.96 and 31,780,111 shares outstanding.

The shares to be sold were originally acquired as restricted stock units from the issuer in two grants: 4,466 shares on 09/01/2017 and 4,880 shares on 09/01/2018, both fully paid via RSU awards rather than cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for NVMI disclose?

The Form 144 discloses a planned sale of 9,346 NVMI ordinary shares under Rule 144. The shares are to be sold through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $4,147,380.96, based on the figures in the notice.

How many Nova (NVMI) shares are proposed to be sold and on which exchange?

The notice covers a potential sale of 9,346 NVMI ordinary shares. The filing indicates these shares may be sold on the Nasdaq market, using Oppenheimer & Co. Inc. as the broker, consistent with typical Rule 144 transaction disclosure requirements.

What is the aggregate market value of the NVMI shares in this Form 144?

The aggregate market value of the NVMI ordinary shares covered by the Form 144 is $4,147,380.96. This figure reflects the total market value for the 9,346 shares indicated as potentially being sold through the broker on Nasdaq.

How were the NVMI shares in this Form 144 originally acquired?

The NVMI shares were originally acquired through restricted stock unit (RSU) awards from the issuer. The holder received 4,466 shares on 09/01/2017 and 4,880 shares on 09/01/2018, with the nature of payment noted as RSU grants rather than cash purchases.

What does the Form 144 say about NVMI shares outstanding?

The Form 144 notes that 31,780,111 NVMI ordinary shares were outstanding. This number provides context for the size of the planned 9,346-share sale, indicating the total share count against which the potential sale is measured at the time of the notice.

When is the approximate sale date for the NVMI shares in this Form 144?

The filing lists an approximate sale date of 02/17/2026 for the NVMI ordinary shares. This date reflects when the holder expects to begin selling the 9,346 shares referenced, subject to market conditions and Rule 144 requirements noted in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001961103
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NOVA LTD.
SEC File Number	000-30668
Address of Issuer	5 DAVID FIKES STREET REHOVOT ISRAEL 7610201
Phone	972-73-229-5600
Name of Person for Whose Account the Securities are To Be Sold	Wolfing Shay
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	9346	4147380.96	31780111	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/01/2017	RSU	Issuer			4466	09/01/2017	N/A
Ordinary	09/01/2018	RSU	Issuer			4880	09/01/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 11/13/2025
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Shay Wolfling
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)